Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2010
05/04/2010CA2448863C Increased and sustained in vivo gene expression using a nucleic acid, histone, and amphipathic compound composition
05/04/2010CA2421492C Method of sequencing dna
05/04/2010CA2418395C Protein induced by homogeneous blood transfusion and dna encoding the same
05/04/2010CA2412880C Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product
05/04/2010CA2398362C Homogenous assay of duplex or triplex hybridization by means of multiple measurements under varied conditions
05/04/2010CA2384122C Cyclic depsipeptide synthetase and gene thereof, and mass production system for cyclic depsipeptide
05/04/2010CA2367636C Fusion proteins
05/04/2010CA2347178C Methods of inhibiting smooth muscle cell proliferation and preventing restenosis with a vector expressing rb2/p130
05/04/2010CA2335364C Use of bi-specific antibodies for pre-targeting diagnosis and therapy
05/04/2010CA2299624C Mammalian cytokine receptor - 11
05/04/2010CA2281920C Compositions and methods for modulating cellular nf-.kappa.b activation
05/04/2010CA2223503C Transferrin receptor genes
05/04/2010CA2213394C Method to obtain male sterile plants
05/04/2010CA2172398C Methods and products for controlling immune responses in mammals
05/04/2010CA2140638C Generation of xenogeneic antibodies
05/04/2010CA2089376C Sugar modified oligonucleotides that detect and modulate gene expression
05/04/2010CA1341604C Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon-like polypeptides
04/2010
04/29/2010WO2010048615A2 Human ebola virus species and compositions and methods thereof
04/29/2010WO2010048590A1 Methods and compositions for prevention or treatment of rsv infection using modified duplex rna molecules
04/29/2010WO2010048586A1 Multiple exon skipping compositions for dmd
04/29/2010WO2010048568A1 Modified photosynthetic microorganisms for producing triglycerides
04/29/2010WO2010048522A1 Thermostable cellulase and methods of use
04/29/2010WO2010048444A1 Use of t-loop in trans-splicing polynucleotides
04/29/2010WO2010048352A2 Methods for treating eye disorders
04/29/2010WO2010048337A2 Preservation of information related to genomic dna methylation
04/29/2010WO2010048322A1 Use of e. coli surface antigen 3 sequences for the export of heterologous antigens
04/29/2010WO2010048317A2 Micro-rnas as markers for tumor progression
04/29/2010WO2010048228A2 Compositions and methods for inhibiting expression of transthyretin
04/29/2010WO2010048123A2 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
04/29/2010WO2010047955A2 N-linked glycosylation alteration in e0 and e2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
04/29/2010WO2010047835A2 Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
04/29/2010WO2010047829A1 Mutant hepatitis c virus e2 polypeptides for hcv treatment
04/29/2010WO2010047519A2 Heart tissue specific gene mmh1
04/29/2010WO2010047509A2 Anti-dr5 antibody with improved affinity and stability, and composition for cancer prevention or treatment including same
04/29/2010WO2010047448A1 Diagnostic kit of colon cancer using colon cancer related marker,and diagnostic method thereof
04/29/2010WO2010047423A1 Method for introducing mutated gene, gene having mutation introduced therein, cassette for introducing mutation, vector for introducing mutation, and knock-in non-human mammal
04/29/2010WO2010047419A1 Immobilization substrate and method for producing the same
04/29/2010WO2010047347A1 Process for producing protein capable of forming inclusion body
04/29/2010WO2010047317A1 Novel marker for detecting interstitial cystitis
04/29/2010WO2010047310A1 Tumor antigen peptide and use thereof
04/29/2010WO2010047240A1 Method for predicting risk of exudative age-related macular degeneration
04/29/2010WO2010047216A1 METHOD FOR INHIBITING FUNCTION OF micro-RNA
04/29/2010WO2010047211A1 Method for determining presence or absence of abnormal cell
04/29/2010WO2010047188A1 Process for producing l- and d-aliphatic amino acid hydroxides
04/29/2010WO2010047062A1 Rab6kifl/kif20a epitope peptide and vaccines containing the same
04/29/2010WO2010047047A1 Tannase, gene encoding same, and process for producing same
04/29/2010WO2010047028A1 Screening method of anti-lung or esophageal cancer compounds
04/29/2010WO2010046930A1 Pcr based diagnostic kit and methods for amplification and detection of pathogens
04/29/2010WO2010046918A1 Purification of supercoiled plasmid dna
04/29/2010WO2010046786A1 Meganuclease recombination system
04/29/2010WO2010046778A2 Novel shigella frotein antigens and methods
04/29/2010WO2010046530A1 Methods and uses involving genetic aberrations of nav3 and aberrant expression of multiple genes
04/29/2010WO2010046519A1 Animal model of human angiogenesis and applications thereof
04/29/2010WO2010046493A2 Gene transfer vectors comprising at least one isolated dna molecule having insulator and or boundary properties and methods to identify the same
04/29/2010WO2010046471A2 A method for producing a transgenic cell with increased gamma-aminobutyric acid (gaba) content
04/29/2010WO2010046250A1 Nucleic acids with enhanced expression characteristics
04/29/2010WO2010046221A1 Plants with increased yield (nue)
04/29/2010WO2010045949A2 A method and apparatus for analysis of a particle
04/29/2010WO2010045865A1 PROBES FOR DETECTING MUTATIONS OF kRas GENE, LIQUICHIP AND DETECTION METHODS THEREOF
04/29/2010WO2010045679A1 Transcriptional control elements and uses therefor
04/29/2010WO2010028054A8 Compositions and methods for inhibiting expression of mutant egfr gene
04/29/2010WO2010027830A3 Methods for modulation of connective tissue growth factor expression
04/29/2010WO2010027279A3 Compositions and methods for the treatment and prevention of neoplastic disorders
04/29/2010WO2010025466A3 Transgenic plants with enhanced growth characteristics
04/29/2010WO2010024924A3 Hydrolases, nucleic acids encoding them and methods for making and using them
04/29/2010WO2010023491A3 Plant pathogen resistance
04/29/2010WO2010023327A3 Method for obtaining oligonucleotide aptamers and uses thereof
04/29/2010WO2010021868A3 Improvement of nitrogen responsiveness in plants
04/29/2010WO2010017198A3 Fgfr extracellular domain acidic region muteins
04/29/2010WO2010008576A3 Idna vaccines and methods for using the same
04/29/2010WO2010008562A3 Methods and materials for producing transgenic animals
04/29/2010WO2010006804A8 Method to obtain transgenic plants resistant to phytopathogen attack based on rna interference (rnai)
04/29/2010WO2010006237A3 Phosphorothioate oligonucleotides non-nucleosidic phosphorothiotes as delivery agents for irna agents
04/29/2010WO2010004204A3 Fgf-r4 receptor-specific antagonists
04/29/2010WO2009158658A3 Induction of flocculation in photosynthetic organisms
04/29/2010WO2009158470A3 Toxin genes and methods for their use
04/29/2010WO2009157683A3 Rt-pcr method using n-primer and kit for rt-pcr comprising n-primer
04/29/2010WO2009154835A3 Compositions and methods related to mir-16 and therapy of prostate cancer
04/29/2010WO2009152387A3 Compositions comprising cmyc sirna and methods of use thereof
04/29/2010WO2009149083A3 Non-hemolytic clya for excretion of proteins
04/29/2010WO2009147538A3 Dense and erect panicle gene and uses thereof
04/29/2010WO2009141541A3 Use of kif13a and ap-1 inhibitors for inhibiting melanogenesis
04/29/2010US20100107283 Chimeric Regulatory Elements for Gene Expression in Leaf Mesophyll and Bundle Sheath Cells
04/29/2010US20100107282 Thermostable cellulase and methods of use
04/29/2010US20100107280 kernel productivity of plants through the modulation of glutamine synthetase activity
04/29/2010US20100107279 Yield-related polynucleotides and polypeptides in plants
04/29/2010US20100107278 Expression Cassettes For Root-Preferential Expression In Plants
04/29/2010US20100107277 Flavonoid 3',5' hydroxylase gene sequences and uses therefor
04/29/2010US20100107275 Broadly expressing regulatory regions
04/29/2010US20100107272 Cotton variety mcs0747b2rf
04/29/2010US20100107271 Cotton variety mx0623b2rf
04/29/2010US20100107270 Cotton variety mx0622b2rf
04/29/2010US20100107269 Cotton variety mcs0711b2rf
04/29/2010US20100107268 Cotton variety mcs0702b2rf
04/29/2010US20100107267 Cotton variety mcs0701b2rf
04/29/2010US20100107264 Development of influenza a antivirals
04/29/2010US20100107263 C-reactive protein (crp) knockout mouse
04/29/2010US20100105878 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor
04/29/2010US20100105876 Method for the oligomerisation of peptides
04/29/2010US20100105760 Treatment of Apolipoprotein-A1 Related Diseases by Inhibition of Natural Antisense Transcript to Apolipoprotein-A1
1 ... 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 ... 4023